Bristol-Myers Squibb Co. BMY
HEALTHCARE · DRUG MANUFACTURERS - GENERALi
Market dataready · fetched 2026-11-07T03:48:45.320Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-07T00:16:40.322162234Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-07T03:48:44.830453+00:00
Bristol-Myers Squibb Co. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 64.67 | 29.7% | 4.2% | 59.74 | 38.3% | 4.8% |
| 25Δ | 64.30 | 30.8% | 3.8% | 60.25 | 38.6% | 4.2% |
| 30Δ | 63.92 | 31.7% | 3.3% | 60.78 | 37.6% | 3.5% |
| 35Δ | 63.54 | 31.8% | 2.9% | 61.24 | 37.5% | 3.1% |
| 40Δ | 63.17 | 31.9% | 2.6% | 61.65 | 37.9% | 2.7% |
| 45Δ | 62.81 | 31.9% | 2.2% | 62.07 | 38.2% | 2.3% |
| 50Δ | 62.46 | 31.8% | 1.9% | 62.48 | 37.8% | 2.0% |
| 55Δ | 62.11 | 31.7% | 1.6% | 62.89 | 37.4% | 1.6% |
| 60Δ | 61.78 | 31.0% | 1.4% | 63.37 | 38.8% | 1.4% |
| 65Δ | 61.46 | 30.1% | 1.1% | 63.89 | 41.0% | 1.2% |
| 70Δ | 61.14 | 29.1% | 0.9% | 64.38 | 40.7% | 1.0% |
| 75Δ | 60.73 | 29.4% | 0.7% | 64.86 | 39.8% | 0.7% |
| 80Δ | 60.23 | 30.6% | 0.6% | 66.22 | 49.0% | 0.7% |
20Δ
- Pseudo strike
- 64.67
- IV
- 29.7%
- B/E move
- 4.2%
- Pseudo strike
- 59.74
- IV
- 38.3%
- B/E move
- 4.8%
25Δ
- Pseudo strike
- 64.30
- IV
- 30.8%
- B/E move
- 3.8%
- Pseudo strike
- 60.25
- IV
- 38.6%
- B/E move
- 4.2%
30Δ
- Pseudo strike
- 63.92
- IV
- 31.7%
- B/E move
- 3.3%
- Pseudo strike
- 60.78
- IV
- 37.6%
- B/E move
- 3.5%
35Δ
- Pseudo strike
- 63.54
- IV
- 31.8%
- B/E move
- 2.9%
- Pseudo strike
- 61.24
- IV
- 37.5%
- B/E move
- 3.1%
40Δ
- Pseudo strike
- 63.17
- IV
- 31.9%
- B/E move
- 2.6%
- Pseudo strike
- 61.65
- IV
- 37.9%
- B/E move
- 2.7%
45Δ
- Pseudo strike
- 62.81
- IV
- 31.9%
- B/E move
- 2.2%
- Pseudo strike
- 62.07
- IV
- 38.2%
- B/E move
- 2.3%
50Δ
- Pseudo strike
- 62.46
- IV
- 31.8%
- B/E move
- 1.9%
- Pseudo strike
- 62.48
- IV
- 37.8%
- B/E move
- 2.0%
55Δ
- Pseudo strike
- 62.11
- IV
- 31.7%
- B/E move
- 1.6%
- Pseudo strike
- 62.89
- IV
- 37.4%
- B/E move
- 1.6%
60Δ
- Pseudo strike
- 61.78
- IV
- 31.0%
- B/E move
- 1.4%
- Pseudo strike
- 63.37
- IV
- 38.8%
- B/E move
- 1.4%
65Δ
- Pseudo strike
- 61.46
- IV
- 30.1%
- B/E move
- 1.1%
- Pseudo strike
- 63.89
- IV
- 41.0%
- B/E move
- 1.2%
70Δ
- Pseudo strike
- 61.14
- IV
- 29.1%
- B/E move
- 0.9%
- Pseudo strike
- 64.38
- IV
- 40.7%
- B/E move
- 1.0%
75Δ
- Pseudo strike
- 60.73
- IV
- 29.4%
- B/E move
- 0.7%
- Pseudo strike
- 64.86
- IV
- 39.8%
- B/E move
- 0.7%
80Δ
- Pseudo strike
- 60.23
- IV
- 30.6%
- B/E move
- 0.6%
- Pseudo strike
- 66.22
- IV
- 49.0%
- B/E move
- 0.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 27.29% | |
| 27.02% | |
| 26.23% | |
| 26.33% | |
| 25.43% | |
| 26.36% | |
| 28.24% | |
| 28.99% | |
| 26.50% | |
| 27.69% | |
| 27.75% | |
| 27.30% | |
| 26.29% | |
| 23.28% | |
| 24.88% | |
| 24.48% | |
| 24.77% | |
| 24.90% | |
| 23.24% | |
| 26.60% | |
| 27.50% | |
| 26.95% | |
| 24.92% | |
| 26.63% | |
| 26.52% | |
| 28.55% | |
| 25.71% | |
| 25.28% | |
| 26.49% | |
| 27.90% | |
| 27.40% | |
| 29.42% | |
| 27.94% | |
| 29.21% | |
| 34.88% | |
| 30.57% | |
| 31.05% | |
| 32.42% | |
| 31.31% | |
| 31.68% | |
| 45.60% | |
| 33.10% | |
| 34.65% | |
| 34.38% | |
| 34.88% | |
| 35.55% | |
| 34.09% | |
| 36.89% | |
| 38.27% | |
| 37.70% | |
| 41.31% | |
| 40.85% | |
| 43.87% | |
| 46.41% | |
| 47.57% | |
| 35.38% | |
| 32.17% |
Drug Manufacturers - General
GILD
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the…
More →GRFS
Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
More →GSK
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related…
More →JNJ
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a…
More →LLY
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125…
More →MRK
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in…
More →